Press Releases April 23, 2026 08:30 AM

ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call

ICU Medical schedules first quarter 2026 earnings release and conference call for May 7, 2026.

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
ICUI

ICU Medical, a Nasdaq-listed leader in medical infusion products, announced the date and time for its first quarter 2026 earnings release and conference call. The earnings will be published on May 7, during which management will discuss the financial results and operational updates. Investors and analysts will have access to the call via phone and webcast.

ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call
ICUI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • ICU Medical will release Q1 2026 earnings on May 7, 2026 at 4:00 p.m. ET.
  • A conference call and webcast will follow at 4:30 p.m. ET for management to discuss results.
  • ICU Medical specializes in infusion systems and critical care products across hospital and home care settings, emphasizing innovation and quality.

SAN CLEMENTE, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2026 earnings release and conference call.

The Company will release its first quarter 2026 results on Thursday, May 7, 2026 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, May 7, 2026. The call can be accessed at 1-800-343-4136, conference ID “ICUMED”. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.

About ICU Medical

ICU Medical (Nasdaq: ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com.

CONTACT:
ICU Medical
Brian Bonnell, Chief Financial Officer
(949) 366-2183

ICR, Inc.
John Mills, Managing Partner
(646) 277-1254

Source: ICU Medical, Inc.


Risks

  • Earnings results may not meet market expectations, potentially impacting investor sentiment in the healthcare equipment sector.
  • No specific guidance or preliminary financial results disclosed ahead of the release, introducing uncertainty for stakeholders.
  • Market or regulatory changes affecting hospital and home healthcare demand could influence ICU Medical’s performance post-earnings.

More from Press Releases

Blaize Provides Preliminary Third Quarter 2026 Revenue Update and Full-Year Guidance Update Oct 5, 2026 Spyre Therapeutics Announces Pricing of $350.0 Million Public Offering of Common Stock Oct 5, 2026 IPG Defense to Display CROSSBOW™ High-Energy Laser Systems at Land Forces 2026 in Perth Oct 5, 2026 LGI Homes, Inc. Reports September and Third Quarter 2026 Home Closings and Announces Date for Third Quarter Earnings Conference Call Oct 5, 2026 Skyworks Announces Expiration and Final Results of Exchange Offers for Qorvo’s Senior Notes due 2029 and 2031 Oct 5, 2026